Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.8/5
Stevanato Group SpA (STVN US)
Watchlist
7
Analysis
Health Care
•
Italy
Stevanato Group Societa' Per Azioni manufactures packaging containers from glass. The Company provides vials, ampoules, auto-injectors, and prefilled syringes for pharmaceutical industry. Stevanato Group serves customers worldwide.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Stevanato Group SpA
•
16 Jul 2025 06:00
Stevanato Group Is Future-Proofing Pharma with AI-Pricing
Stevanato Group's first quarter of fiscal 2025 results showcase both strengths and challenges in their operational execution, highlighting the...
Baptista Research
Follow
196 Views
Share
bullish
•
Stevanato Group SpA
•
04 Apr 2025 20:00
Stevanato Group: Expanding Manufacturing Capacity To Enable Future Top-Line Growth!
Stevanato Group has reported its financial results for fiscal year 2024, giving investors a comprehensive view of its performance, strategic...
Baptista Research
Follow
410 Views
Share
bullish
•
Stevanato Group SpA
•
03 Jan 2025 07:00
Stevanato Group: Engineering Optimization For A Competitive Edge But Will It Work? - Major Drivers
Stevanato Group's third-quarter 2024 financial results present a complex picture that warrants a balanced examination of both its organizational...
Baptista Research
Follow
568 Views
Share
bullish
•
Stevanato Group SpA
•
16 Oct 2024 06:00
Stevanato Group S.p.A.: Expansion & Efficiency In Product Lines & Other Major Drivers
Stevanato Group has presented a mixed performance in the second quarter of 2024, which led to revised expectations for its annual outlook. On the...
Baptista Research
Follow
238 Views
Share
bullish
•
Stevanato Group SpA
•
14 Oct 2024 08:00
Stevanato Group S.p.A.: What Is Their Market Outlook & How Are They Adapting To Customer and Regulatory Requirements? - Major Drivers
Stevanato Group's second quarter 2024 earnings results reflect a mixed performance characterized by robust revenue growth in the Biopharmaceutical...
Baptista Research
Follow
222 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.58.5
x